Department of Oncology
School of Medicine Queen's University

Disease Site Groups


Multidisciplinary management of patients with cancer is now a standard of care in the province of Ontario. In order to provide optimal care for our patients, the Cancer Program is organized in Disease Site Groups (DSGs).

The role of a DSG is to provide comprehensive leadership in the diagnosis and management of cancer patients that is based on the best known evidence and is delivered in a way that respects the preferences of patients. The focus of a DSG is to meet the needs of a population of patients with cancer. DSG’s are physician-led but multidisciplinary in their composition.

Membership in the DSG will include all medical disciplines involved in the site, as well as representation from nursing and other health disciplines. Membership must be in compliance with Cancer Care Ontario (CCO’s) Multidisciplinary Cancer Conference (MCC) requirements. Each DSG has a Chair and Vice Chair(s), as is appropriate, encompassing the major oncology specialties involved in care of patients with the disease(s). Their primary responsibilities will be to provide academic and clinical leadership to the team. To initiate and conduct research activities, including clinical trials, health services, transitional, nursing and supportive research

DSGs are responsible for overseeing Multidisciplinary Case Conferences, development of Cancer Centre of Southeastern Ontario Disease Site Management guidelines and other activities. Please see the full terms of reference

DSG chairs/Vice chairs meet 3-4 times per year as the a Council to discuss common issues, Guideline development and other items .

CCSEO/Department of Oncology Standard Disease Management Guidelines

A rigorous process of guideline development has been established in the Department of Oncology to ensure evidence based and consistent care for our patients. Each new guideline is based on best evidence, is consistent with CCO Disease Site Pathways, is reflective of the care provided at KGH/CCSEO and is developed and approved by the relevant Disease Site Group. Further, all guidelines are discussed and approved by the Disease Site Chairs council

Guidelines developed through this process are available on the relevant Disease Site Group page accessible through the menu to the left.